Cite
APA Citation
Arai, H., Suzuki, H., Yoshiyama, T., Lobello, K., Peng, Y., Liu, E., Ketter, N., Margolin, R., Jackson, N., & Fujimoto, Y. (n.d.). p1–338: Safety, tolerability and immunogenicity of an immunotherapeutic vaccine (vanutide cridificar [ACC‐001]) and the QS‐21 adjuvant in Japanese individuals with mild‐to‐moderate Alzheimer's disease: A phase IIa, multicenter, randomized, adjuvant and placebo clinical trial. Alzheimer's & dementia, 9, P282. http://access.bl.uk/ark:/81055/vdc_100103412957.0x000022